Dr Henry David Knudsen, MD | |
3207 46th Ave Se, Mandan, ND 58554-4729 | |
(701) 250-9701 | |
Not Available |
Full Name | Dr Henry David Knudsen |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 3207 46th Ave Se, Mandan, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710213715 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 3006 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Henry David Knudsen, MD 3207 46th Ave Se, Mandan, ND 58554-4729 Ph: (701) 250-9701 | Dr Henry David Knudsen, MD 3207 46th Ave Se, Mandan, ND 58554-4729 Ph: (701) 250-9701 |
News Archive
Before the therapeutic potential of using human tissue-derived mesenchymal stromal cells (MSC) to treat immune and degenerative diseases can be fully determined, the effects of freeze-thawing and intravenous delivery on MSC function must be understood.
HHS Secretary Kathleen Sebelius today will announce $159.1 million in grants to health care workforce training programs. These grants build on the multimillion dollar investments made under the Affordable Care Act and Recovery Act to strengthen and grow our primary care workforce. The grants will target three types of programs: Nursing Workforce Development programs; interdisciplinary geriatric education and training programs; and Centers of Excellence programs for underrepresented minority students.
Researchers at Okayama University describe in the journal Scientific Reports the role of an extracellular protein, versican, in regulating tumor growth and providing a newly formed network of blood vessels to further nourish the tumor.
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 7 days ago